Edwards Lifesciences Corporation
MX ˙ BMV ˙ US28176E1082
SecurityMX:EW / Edwards Lifesciences Corporation
InstitutionBrookstone Capital Management
Latest Disclosed Ownership2,544 shares
Latest Disclosed Value $ 203,724
Brookstone Capital Management reports 12.73% decrease in ownership of EW / Edwards Lifesciences Corporation

On April 16, 2026 - Brookstone Capital Management filed a 13F-HR form disclosing ownership of 2,544 shares of Edwards Lifesciences Corporation (MX:EW) valued at $203,724 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 15, 2026 disclosing 2,915 shares of Edwards Lifesciences Corporation. This represents a change in shares of -12.73% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-16 2026-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 2,544 -371 -12.73 204 -18.15 0.0023
2026-01-15 2025-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 2,915 -419 -12.57 248 -4.25 0.0028
2025-10-15 2025-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 3,334 -2,181 -39.55 259 -39.91 0.0031
2025-07-30 2025-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 5,515 -133 -2.35 431 5.38 0.0057
2025-04-29 2025-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 5,648 164 2.99 409 0.99 0.0059
2025-01-13 2024-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 5,484 616 12.65 406 26.17 0.0059
2024-10-08 2024-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 4,868 -2,414 -33.15 321 -49.45 0.0047
2024-07-18 2024-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 7,282 -4,993 -40.68 636 -45.87 0.0105
2024-04-15 2024-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 12,275 383 3.22 1,173 29.47 0.0210
2024-01-11 2023-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 11,892 892 8.11 907 19.37 0.0176
2023-10-20 2023-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 11,000 -3,748 -25.41 760 -42.98 0.0167
2023-07-11 2023-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 14,748 6,668 82.52 1,331 96.02 0.0268
2023-04-19 2023-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 8,080 1,676 26.17 679 37.73 0.0132
2023-01-09 2022-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 6,404 269 4.38 493 -2.76 0.0100
2022-10-14 2022-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 6,135 141 2.35 507 -14.07 0.0117
2022-07-11 2022-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 5,994 223 3.86 590 -15.83 0.0131
2022-04-12 2022-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 5,771 5,771 701 0.0137
2021-07-14 2021-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 0 -6,729 -100.00 0 -100.00
2021-04-16 2021-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 6,729 164 2.50 563 -6.01 0.0216
2021-01-13 2020-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 6,565 115 1.78 599 16.31 0.0238
2020-10-13 2020-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 6,450 -628 -8.87 515 5.32 0.0238
2020-07-21 2020-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 7,078 4,488 173.28 489 0.00 0.0305
2020-04-14 2020-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 2,590 -87 -3.25 489 -21.76 0.0281
2020-01-29 2019-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 2,677 -108 -3.88 625 2.12 0.0317
2019-10-18 2019-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 2,785 -345 -11.02 612 5.88 0.0332
2019-07-25 2019-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 3,130 338 12.11 578 8.24 0.0334
2019-04-18 2019-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 2,792 313 12.63 534 40.53 0.0347
2019-02-05 2018-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 2,479 -126 -4.84 380 -16.30 0.0288
2018-11-05 2018-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 2,605 541 26.21 454 51.33 0.0345
2018-08-06 2018-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 2,064 -522 -20.19 300 -16.90 0.0261
2018-04-23 2018-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 2,586 2,586 361 0.0328
2016-04-14 2016-03-31 13F EDWARDS LIFE SCIENCES COM COM 28176E108 0 0 0 0.0000
2016-01-14 2015-12-31 13F EDWARDS LIFE SCIENCES COM COM 28176E108 0 -37 -100.00 0 -100.00
2015-10-28 2015-09-30 13F EDWARDS LIFE SCIENCES COM COM 28176E108 37 0 0.00 5 0.00 0.0009
2015-08-11 2015-06-30 13F EDWARDS LIFE SCIENCES COM COM 28176E108 37 37 5 0.0006
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.